Cocrystal Pharma, Inc. (COCP)
1.13
+0.02
(+1.80%)
USD |
NASDAQ |
Aug 25, 16:00
1.135
0.00 (0.00%)
After-Hours: 19:59
Cocrystal Pharma Total Liabilities (Quarterly) : 3.605M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.605M |
| March 31, 2026 | 3.31M |
| December 31, 2025 | 3.381M |
| September 30, 2025 | 2.777M |
| June 30, 2025 | 3.172M |
| March 31, 2025 | 3.355M |
| December 31, 2024 | 3.933M |
| September 30, 2024 | 3.53M |
| June 30, 2024 | 4.183M |
| March 31, 2024 | 3.961M |
| December 31, 2023 | 4.875M |
| September 30, 2023 | 1.924M |
| June 30, 2023 | 1.597M |
| March 31, 2023 | 3.172M |
| December 31, 2022 | 1.273M |
| September 30, 2022 | 1.738M |
| June 30, 2022 | 2.99M |
| March 31, 2022 | 1.792M |
| December 31, 2021 | 1.843M |
| September 30, 2021 | 1.586M |
| June 30, 2021 | 2.669M |
| March 31, 2021 | 1.793M |
| December 31, 2020 | 1.737M |
| September 30, 2020 | 3.039M |
| June 30, 2020 | 3.423M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.41M |
| December 31, 2019 | 2.823M |
| September 30, 2019 | 2.692M |
| June 30, 2019 | 2.489M |
| March 31, 2019 | 2.471M |
| December 31, 2018 | 21.45M |
| September 30, 2018 | 13.27M |
| June 30, 2018 | 13.68M |
| March 31, 2018 | 16.58M |
| December 31, 2017 | 34.16M |
| September 30, 2017 | 22.26M |
| June 30, 2017 | 22.30M |
| March 31, 2017 | 22.54M |
| December 31, 2016 | 46.48M |
| September 30, 2016 | 53.08M |
| June 30, 2016 | 53.32M |
| March 31, 2016 | 55.82M |
| December 31, 2015 | 73.11M |
| September 30, 2015 | 69.41M |
| June 30, 2015 | 72.61M |
| March 31, 2015 | 79.90M |
| December 31, 2014 | 82.60M |
| September 30, 2014 | 7.657M |
| June 30, 2014 | 6.911M |
| March 31, 2014 | 12.56M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| CNBX Pharmaceuticals, Inc. | 2.672M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 112.90M |
| Fulcrum Therapeutics, Inc. | 13.26M |
| Definium Therapeutics, Inc. | 194.22M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.649M |
| Shareholders Equity (Quarterly) | 1.044M |
| Debt to Equity Ratio | 1.284 |
| Current Ratio | 1.237 |
| Net Debt Paydown Yield | 0.54% |